Apremilast as an Off-Label Therapeutic Agent: A Comprehensive Review of Safety and Efficacy Data in the Literature for Combination Therapy and Inflammatory Dermatoses. J of Skin. 2021;5(3):203-227. doi:10.25251/skin.5.3.2